MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vandenberg, R. J.
Right arrow Articles by Schofield, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vandenberg, R. J.
Right arrow Articles by Schofield, P. R.

The extracellular disulfide loop motif of the inhibitory glycine receptor does not form the agonist binding site

RJ Vandenberg, S Rajendra, CR French, PH Barry and PR Schofield

Garvan Institute of Medical Research, Darlinghurst, NSW, Sydney, Australia.

Inhibitory (glycine and gamma-aminobutyric acid type A) and excitatory (nicotinic acetylcholine and serotonin 5-hydroxytryptamine type 3) receptors of the ligand-gated ion channel superfamily are related by both structural similarities and primary sequence identity. One invariant feature of all members of this receptor superfamily is the presence of an extracellular disulfide loop motif. This structural motif has been modeled, and Cockcroft et al. [Proteins 8:386-397 (1990)] have suggested that it forms the agonist binding site of the ligand-gated ion channel receptors. Using site-directed mutagenesis of the inhibitory glycine receptor (GlyR), we have specifically tested this hypothesis. The lysine residue at position 143 is proposed to form the binding site for the negatively charged carboxyl group of the agonist glycine. Differing residues at this position in other ligand- gated receptors are proposed to confer agonist specificity. The aspartic acid residue at position 148 is an invariant residue in every known subunit of the ligand-gated ion channel receptor superfamily. This residue has been proposed as the binding site for the positively charged amino group of the various agonists. Mutation of the lysine at position 143 to alanine resulted in essentially unaltered GlyRs, showing only modest decreases in strychnine affinity (Kd, 8.1 +/- 1.4 nM versus 13.4 +/- 1.3 nM), glycine displacement of strychnine binding (Ki, 25 +/- 5 microM versus 49 +/- 9 microM), and glycine activation of chloride currents (EC50, 27 +/- 6 microM versus 114 +/- 14 microM). Thus, we conclude that Lys-143 does not play a major role in either agonist or antagonist binding or agonist activation of the GlyR. Mutation of Asp-148 to either alanine or asparagine disrupted the expression and/or assembly of the receptor, and no binding sites or ion channels were expressed on the cell surface. The conservative mutation of the aspartic acid at position 148 to glutamic acid (D148E) allowed the expression of receptors, although with reduced efficiency. The D148E GlyRs showed a 1 order of magnitude decrease in strychnine affinity (Kd, 8.1 +/- 1.4 nM versus 82 +/- 21 nM), without any change in the glycine displacement of strychnine binding (Ki, 25 +/- 5 microM versus 29 +/- 8 microM) or glycine activation of chloride currents (EC50, 27 +/- 6 microM versus 20 +/- 1 microM).(ABSTRACT TRUNCATED AT 400 WORDS)

Volume 44, Issue 1, pp. 198-203, 07/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurosci.Home page
J. G. Newell, R. A. McDevitt, and C. Czajkowski
Mutation of Glutamate 155 of the GABAA Receptor {beta}2 Subunit Produces a Spontaneously Open Channel: A Trigger for Channel Activation
J. Neurosci., December 15, 2004; 24(50): 11226 - 11235.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. L. Absalom, T. M. Lewis, W. Kaplan, K. D. Pierce, and P. R. Schofield
Role of Charged Residues in Coupling Ligand Binding and Channel Activation in the Extracellular Domain of the Glycine Receptor
J. Biol. Chem., December 12, 2003; 278(50): 50151 - 50157.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. Schofield, A. Jenkins, and N. L. Harrison
A Highly Conserved Aspartic Acid Residue in the Signature Disulfide Loop of the {alpha}1 Subunit Is a Determinant of Gating in the Glycine Receptor
J. Biol. Chem., September 5, 2003; 278(36): 34079 - 34083.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. V. Rothlin, E. Katz, M. Verbitsky, and A. B. Elgoyhen
The alpha 9 Nicotinic Acetylcholine Receptor Shares Pharmacological Properties with Type A gamma -Aminobutyric Acid, Glycine, and Type 3 Serotonin Receptors
Mol. Pharmacol., February 1, 1999; 55(2): 248 - 254.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. K. Vassilatis, J. P. Arena, R. H. A. Plasterk, H. A. Wilkinson, J. M. Schaeffer, D. F. Cully, and L. H. T. Van der Ploeg
Genetic and Biochemical Evidence for a Novel Avermectin-sensitive Chloride Channel in Caenorhabditis elegans. ISOLATION AND CHARACTERIZATION
J. Biol. Chem., December 26, 1997; 272(52): 33167 - 33174.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
C.-M. Becker
Review : Glycine Receptors: Molecular Heterogeneity and Implications for Disease
Neuroscientist, May 1, 1995; 1(3): 130 - 141.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics